Clinical & public health researcher on abortion & contraception. MD.
@ansirh.bsky.social Director. @ucsfbixby.bsky.social faculty.
@ibisrh.bsky.social Sr Advisor. Posts not affiliated with UCSF.
Dr. Daniel Grossman
Loading...
It's concerning to see patients in states with abortion bans being offered less effective miscarriage management. When clinicians are unable to provide evidence-based care, we see patients face delays, denials, and worsened health outcomes.
An unbiased review of the 100+ gold standard studies on mifepristone would show that not only is there no rigorous evidence to support political efforts to further restrict medication abortion — the existing restrictions are also medically unnecessary and should be removed.
This research lends further evidence to the reports we have heard from health care providers across the country — many patients are facing substantial barriers to evidence-based miscarriage care in states with abortion bans.
The decision to conduct this review is based on politics and ideology, not science.
Decades of gold-standard scientific evidence have overwhelmingly demonstrated the safety of mifepristone, including when it is provided using telehealth.
Ectopic pregnancies, which occur when an embryo implants somewhere other than the uterine lining, are never viable and can be life-threatening.
Despite this, doctors in Arkansas and Oklahoma attempted to discharge a patient with an ectopic pregnancy without treatment.
As this study suggests, abortion bans have far-reaching impacts on pregnancy care. Our team has documented numerous stories from clinicians who have been unable to provide standard care in these states, leading to delays, denials, and worsened outcomes.
Medical care for pregnant people has become dangerously warped as providers remain hamstrung in states with abortion bans. Every pregnant person in these states is at risk of being denied the care they need.
Medication abortion with mifepristone + misoprostol is still available via telehealth after a recent SCOTUS ruling.
But what will happen if mifepristone access is disrupted again? Fortunately, misoprostol-only abortion is also a safe and effective option.
Abortion bans make it hard and sometimes impossible for people experiencing heartbreaking miscarriages to get proper care.
"This study highlights how these laws are having broad impact on pregnant people," said ANSIRH Director Dr. Daniel Grossman.
Currently, medication abortion is only available through a health care provider, but our research could inform future conversations with the FDA about whether abortion pills could eventually get approved for over-the-counter use.
States with abortion bans are trending away from evidence-based miscarriage treatment that includes mifepristone, compared with states without bans.
Since the overturning of Roe v. Wade, abortion access has become increasingly divided across the United States. Some states have moved to protect abortion rights, while others have banned or heavily…
An updated report presents findings from the Care Post-Roe Study, and shows how health care providers have been unable to provide the standard of care in states with abortion bans since the Supreme Co...
www.medpagetoday.com
Shifts in management may be an unintended effect of abortion restrictions
On Sept. 16, 2024, Emily Waldorf’s daughter found her curled on the floor, bleeding during a dangerous miscarriage at 17 weeks pregnant.
Waldorf and her husband rushed to an Arkansas hospital, expecting emergency care.
Instead, doctors said they could not intervene under the state’s abortion ban.
Video
ProPublica
Exclusive: The FDA has launched a safety study of the abortion pill, also known as mifepristone, a step that could pave the way for the Trump administration to restrict how it is distributed and used.
The FDA’s ongoing review of mifepristone could skip over established science, health experts warn
The effort is expected to take about six months, meaning its results would come after the midterm elections.
